Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_assertion type Assertion NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_head.
- NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_assertion description "[Three major criteria, saccade amplitude, saccade velocity, and presence of gaze-evoked nystagmus, permitted the correct assignment of 90% of the SCA1, 90% of the SCA2, and 93% of the patients with SCA3 to their genetically confirmed patient group and, therefore, may help orient diagnoses of SCA1, SCA2, and SCA3 at early clinical stages of the diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_provenance.
- NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_assertion evidence source_evidence_literature NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_provenance.
- NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_assertion SIO_000772 9506545 NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_provenance.
- NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_assertion wasDerivedFrom befree-20140225 NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_provenance.
- NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_assertion wasGeneratedBy ECO_0000203 NP542609.RASvAQi-pAENlH1-Y56oUpB7lTT3bFBvrMc2i9x20kUxc130_provenance.